No profile data available.
McKesson Corporation (MCK) is a healthcare company in the additional drug wholesale industry, based in Irving, United States, with about 41,600 full-time employees.
It reported revenue of $403.43 billion for fiscal year 2026, up 12.4% from fiscal year 2025, and net income of $4.76 billion. In Q1 2027 (the quarter ended June 30, 2026) revenue was $105.38 billion, up 7.7% from a year before. Its largest business segment, North American Pharmaceutical, brought in 83% of segment revenue in fiscal year 2026. Its market capitalization was $109.46 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
McKesson reported $403.43 billion in revenue for fiscal year 2026, up 12.4% from $359.05 billion in fiscal year 2025. In Q1 2027 revenue was $105.38 billion.
North American Pharmaceutical, with $336.65 billion or 83% of segment revenue in fiscal year 2026. Next: Oncology & Multispecialty (12%) and Medical-Surgical Solutions (3%).
$109.46 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional drug wholesale) include Cencora, Inc. (COR), Cardinal Health, Inc. (CAH), BrightSpring Health Services, Inc. (BTSG), Harrow, Inc. (HROW).